ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New Jersey » Pulmonary Disease

Top Pulmonary Disease Prescribers in New Jersey

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MAZHAR ELAMIR

Pulmonary Disease

33,170

$2.35M

1034
610 are 65+

18%
patients receiving schedule two controlled substances

Avg: 2%

6%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 56%

$71
Average prescription price

Avg: $137

JOSE PINAL MD

Pulmonary Disease

19,742

$1.74M

362
314 are 65+

23%
patients receiving schedule two controlled substances

Avg: 2%

10%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

44%
prescriptions for brand name drugs

Avg: 56%

$88
Average prescription price

Avg: $137

HEMANTKUMAR PATEL MD

Pulmonary Disease

19,480

$1.13M

723
575 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 56%

$58
Average prescription price

Avg: $137

MARIO PELLETIER M.D.

Pulmonary Disease

18,139

$1.18M

574
504 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

3%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 56%

$65
Average prescription price

Avg: $137

EDWARD MEZIC MD

Pulmonary Disease

17,111

$1.03M

519
467 are 65+

16%
patients receiving schedule two controlled substances

Avg: 2%

4%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 56%

$60
Average prescription price

Avg: $137

LIVIU RAPPAPORT M.D.

Pulmonary Disease

16,255

$1.17M

550
475 are 65+

13%
patients receiving schedule two controlled substances

Avg: 2%

7%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 56%

$72
Average prescription price

Avg: $137

JACKSON OKOYA MD

Pulmonary Disease

14,180

$982K

580
391 are 65+

16%
patients receiving schedule two controlled substances

Avg: 2%

6%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 56%

$69
Average prescription price

Avg: $137

AVTAR PARHAR MD FCCP

Pulmonary Disease

13,482

$1.32M

610
481 are 65+

11%
patients receiving schedule two controlled substances

Avg: 2%

5%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 56%

$98
Average prescription price

Avg: $137

ARTHUR PACIA MD

Pulmonary Disease

12,525

$1.06M

411
358 are 65+

9%
patients receiving schedule two controlled substances

Avg: 2%

6%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 56%

$85
Average prescription price

Avg: $137

MAURICE SHEETZ M.D., C.C.D.

Pulmonary Disease

9,980

$1.17M

515
385 are 65+

9%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 56%

$117
Average prescription price

Avg: $137

PANKAJA ACHAR MD

Pulmonary Disease

9,302

$543K

290
204 are 65+

7%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 56%

$58
Average prescription price

Avg: $137

DEELIP CHATTERJEE M.D.

Pulmonary Disease

9,039

$729K

295
162 are 65+

19%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 56%

$81
Average prescription price

Avg: $137

PETER CURRERI DO

Pulmonary Disease

7,328

$428K

309
249 are 65+

12%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 56%

$58
Average prescription price

Avg: $137

GREGORY MAGEE MD

Pulmonary Disease

6,448

$967K

441
408 are 65+

2%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

46%
prescriptions for brand name drugs

Avg: 56%

$150
Average prescription price

Avg: $137

JOSEPH CURRERI DO

Pulmonary Disease

6,180

$409K

318
279 are 65+

9%
patients receiving schedule two controlled substances

Avg: 2%

5%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 56%

$66
Average prescription price

Avg: $137

SELWYN LEVINE MD

Pulmonary Disease

6,096

$794K

471
436 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

48%
prescriptions for brand name drugs

Avg: 56%

$130
Average prescription price

Avg: $137

RICHARD IORIO M.D.

Pulmonary Disease

5,808

$528K

235
212 are 65+

12%
patients receiving schedule two controlled substances

Avg: 2%

14%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 56%

$91
Average prescription price

Avg: $137

ALAN COHEN D.O. F.C.C.P.

Pulmonary Disease

5,724

$554K

445
335 are 65+

6%
patients receiving schedule two controlled substances

Avg: 2%

4%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 56%

$97
Average prescription price

Avg: $137

ILIA SEGAL MD

Pulmonary Disease

5,706

$1.71M

323
308 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

59%
prescriptions for brand name drugs

Avg: 56%

$300
Average prescription price

Avg: $137

EDWARD FEIN MD

Pulmonary Disease

5,704

$758K

578
521 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

49%
prescriptions for brand name drugs

Avg: 56%

$133
Average prescription price

Avg: $137

JOHN BERMINGHAM DO

Pulmonary Disease

5,651

$736K

228
165 are 65+

8%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

41%
prescriptions for brand name drugs

Avg: 56%

$130
Average prescription price

Avg: $137

JAMES LOGOTHETIS M.D.

Pulmonary Disease

5,404

$508K

384
370 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

3%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 56%

$94
Average prescription price

Avg: $137

DONALD HUSTON D.O.

Pulmonary Disease

5,191

$536K

458
374 are 65+

6%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 56%

$103
Average prescription price

Avg: $137

LOUIS SANGOSSE M.D.

Pulmonary Disease

5,088

$449K

253
225 are 65+

12%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 56%

$88
Average prescription price

Avg: $137

KISHORE RATKALKAR MD

Pulmonary Disease

4,870

$467K

332
282 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

4%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 56%

$96
Average prescription price

Avg: $137

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank